Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study.

British journal of cancer - 15 Nov 2004

Bjørge T, Lie A K, Hovig E, Gislefoss R E, Hansen S, Jellum E, Langseth H, Nustad K, Tropé C G, Dørum A

Abstract excerpt

The aims of the present study were to find the frequency of the most common BRCA1 mutations in women with ovarian tumours identified from a population-based cancer registry and in the general population, to estimate the relative risk of ovarian tumours among the mutation carriers, and to explore the value of using CA125 as a prediagnostic test. The study was designed as a nested case-control study within a cohort...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CA-125 Antigen
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Norway

Share to Odds Ratio

Share to Ovarian Neoplasms

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 15477862
DOI: 10.1038/sj.bjc.6602199
PMCID: PMC2410048

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study.PMID 15477862Read ↗

BRCA mutation testing and association with oncologic outcome and incidence of ovarian cancer in Norway.Semantic proximity Read ↗

Hereditary ovarian cancer in Poland.Semantic proximity Read ↗

Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention.Semantic proximity Read ↗

BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study.Semantic proximity Read ↗

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East PolandSemantic proximity Read ↗

Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA.Semantic proximity Read ↗

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.Semantic proximity Read ↗

Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases.Semantic proximity Read ↗

Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from western Sweden.Semantic proximity Read ↗

The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.Semantic proximity Read ↗

High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.Semantic proximity Read ↗

High incidence of mutations in BRCA1 and BRCA2 genes in ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.